Form SCHEDULE 13G FutureCorp Space Acquisi Filed by: Linden Capital L.P.
http://archive.fast-edgar.com/20260611/A72ZV62EZZ2R6ZZU22TC2ZYMMSVRZZ22ZI82
Filed on: June 11, 2026
Form 8-K Theriva Biologics, Inc. For: Jun 11
http://archive.fast-edgar.com/20260611/AKB4222C8Z22UTZ222ZH2ZZZBCBFZ2T2N286
Filed on: June 11, 2026
Form 8-K Enliven Therapeutics, For: Jun 11
false 0001672619 0001672619 2026-06-11 2026-06-11
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 11, 2026
Enliven Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-39247 81-1523849 (State or other... (continue reading...)
Form D/A Pro Athlete Community
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form D VA-0226 Fund I, a series
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B2 CITIGROUP INC
-
Form D EA-0507 Fund I, a series
-
Form SCHEDULE 13G Long Table Growth Corp. Filed by: Linden Capital L.P.
-
Form 424B3 1st FRANKLIN FINANCIAL
-
Form 8-K MAYS J W INC For: Jun 11
-
Form 8-K InspireMD, Inc. For: Jun 11
-
Form D LO-0513 Fund I, a series
-
Form D NonPublic Industrial AI
-
Form 8-K Caribou Biosciences, For: Jun 11
-
Form 6-K Super Group (SGHC) Ltd For: Jun 11
-
Form 8-K Vera Bradley, Inc. For: Jun 11
-
Form 6-K IsoEnergy Ltd. For: Jun 11
-
Form 10-Q MAYS J W INC For: Apr 30
-
Form 424B3 1st FRANKLIN FINANCIAL
-
Form 6-K MINISO Group Holding For: Jun 11
-
Form 8-K Prairie Operating Co. For: Jun 10
-
Form 424B4 RMG ML Sports Holdings
-
Form 6-K QTREX Quantum Ltd. For: Jun 11
-
Form 8-K ATOSSA THERAPEUTICS, For: Jun 10
-
Form 1-U Naqi Logix Inc. For: Jun 11
-
Form 8-K ARROW FINANCIAL CORP For: Jun 09
-
Form D/A Pam AI Mar 2026 a Series
-
Form 6-K NOVARTIS AG For: Jun 11
-
Form 8-K Rafael Holdings, Inc. For: Jun 11
-
Form 4 Vipshop Holdings Ltd For: Jun 09 Filed by: Wang Yuhua
-
Form D YAR Ventures L.P.
-
Form 425 DANA Inc Filed by: Eaton Corp plc
-
Form 425 DANA Inc Filed by: Eaton Corp plc
-
Form 8-K Summit Therapeutics Inc. For: Jun 10
-
Form N-CEN UNIFIED SERIES TRUST For: Mar 31
-
Form S-4/A Exascale Labs Inc. Filed by: D. Boral ARC Acquisition I Corp.
-
Form 144 Fiverr International Filed by: Levy Dadon Esther
-
Form 6-K THOMSON REUTERS CORP For: Jun 11
-
Form DEFA14A Organon & Co.
-
Form 8-K Silence Therapeutics For: Jun 11
-
Form 6-K AURORA CANNABIS INC For: Jun 11
-
Form FWP Swarmer, Inc Filed by: Swarmer, Inc
-
Form 144 Seagate Technology Holdi Filed by: Romano Gianluca
-
Form 8-K Rigetti Computing, Inc. For: Jun 09
-
Form 6-K NOVONIX Ltd For: Jun 11
-
Form 6-K Alithya Group inc For: Mar 31
-
Form 8-K Driven Brands Holdings For: Jun 11
-
Form 4 Matador Resources Co For: Jun 09 Filed by: Stetson Glenn W
-
Form 4 Matador Resources Co For: Jun 09 Filed by: Foran Joseph Wm
-
Form 10-K McGraw Hill, Inc. For: Mar 31
-
Form 8-K Xeris Biopharma Holdings For: Jun 10
-
Form 6-K AC Immune SA For: Jun 11
-
Form 8-K McGraw Hill, Inc. For: Jun 11
-
Form 144 Seagate Technology Holdi Filed by: MOSLEY WILLIAM D
-
Form 6-K Kanzhun Ltd For: Jun 11
